The tweet was deleted by the author.
But we saved everything 🙂.
CME Group reported that farmer sentiment rose in March, with the AgBarometer increasing to 127 from 116 in February.
The improvement was attributed to an increase in producers' expectations for the future. Details were provided in a statement released by the company.
View post on X Loading...
CME Group ($295.30) is trading well below its MA-20 ($303.56) and MA-50 ($305.78), indicating active short- and medium-term selling pressure. The Ichimoku Kijun on D1 sits at $306.74, making this level immediate resistance, while near-term support is at the MA-100 ($290.27) and more distant key support aligns with the MA-200 ($280.69).
Momentum indicators on D1 continue to show strong bearish bias, with MACD signaling a sell and ADX suggesting weak directional strength. Both RSI (42.05) and CCI (-85.69) lean toward oversold conditions, while Stoch RSI hovers in a neutral range. BBP is deeply negative and oversold, showing clear short-term seller dominance. CME has fallen $9.81 (3.22%) from last week’s close at $305.11, with the current price at the very bottom of the weekly range and weekly volatility standing at 6.34%. The week reflects a steady decline from the highs, confirmed by the dominance of bearish technicals. In today’s session, the stock is under pressure, falling 1.21% and approaching key weekly support.
Looking ahead, next week’s expected range is $287.00 to $305.00, which accommodates the recent drop and aligns with typical weekly volatility. The probability of a price increase is very low (less than 20%), with a further decrease more likely given the strong sell readings in all D1 and most W1 trend indicators. Baseline scenario sees CME consolidating between $287.00 and $305.00. A bullish scenario would require a close above immediate resistance at $303.56–$306.74, while a bearish breakdown could push toward $287.00 or even the broader MA-200 support at $280.69. This range keeps CME well above the 52-week low ($251.90) but distant from its 52-week high ($329.16), marking a cautious, defensive outlook for the next several days.
Previously it was reported that CME Group was exhibiting short-term bearish momentum amid elevated downside risks and limited recovery prospects. This article adds new perspective by highlighting recent shifts in sentiment, with traders advised to watch for confirmation of a trend reversal at key technical thresholds.